Clinical trials
Recruiting Diabetes Mellitus, Type 2 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Imperial College London | 5 |
| University of Leicester | 5 |
| Eli Lilly and Company | 2 |
| University of Cambridge | 2 |
| Amgen | 1 |
| Ascletis Pharma (China) Co., Limited | 1 |
| Boehringer Ingelheim | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Canterbury Christ Church University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 39 |
| Obesity | 14 |
| Overweight | 6 |
| Diabetes Mellitus, Type 1 | 5 |
| Diabetes Mellitus | 4 |
| Fibrosis | 3 |
| Carcinoma, Hepatocellular | 2 |
| Cardiovascular Diseases | 2 |
| Heart Failure | 2 |
| Hypertension | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.